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profiles, the MC code used was PENELOPE extended to 
protons (PENH). The transfer function is obtained from 
interpolation of a table of analytical fits to previously MC 
simulated responses of the camera. Optical and spectral 
properties of the incident proton beam are also taken into 
account in both MC and analytical models. Neutrons 
contribute to the total signal as a flat background with 
notable uncertainties and with no impact on the range shift 
estimation and are therefore not simulated.The analytical 
model was benchmarked against MC simulations and 
experiments for various configurations of a cylindrical 
phantom with inserts of different tissue-equivalent materials. 
It was also benchmarked against MC in patients. We present 
here the results for a critical configuration as shown in the 
figure (part (b)). The proton incident energy was set to 110 
MeV. Protons are expected to stop at the interface between 
muscle (G452) and lung (LN 300) equivalent tissues. 
Results: For the results shown in the figure (part (c)), 
excellent agreement is observed between the analytical 
model and MC: 99.7% of the points for PG emission passing a 
gamma 3%/1 mm criteria and an agreement within 0.6 mm 
for the estimation of range shifts. Agreement between the 
analytical model and measurements (MS) is within 0.4 mm for 
range shifts. The measured signal was corrected for the 
contribution of the neutrons by matching the average of 
measured values to the average of MC values. Typical 
computing time for the analytical model is between 50 to 150 
ms for a single spot. 
Conclusions: A fast and accurate analytical model has been 
validated in phantom and CT geometries for an existing 
prompt gamma camera prototype. The analytical model can 
now be used for future implementation of the system in 
clinical practice.  
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Purpose/Objective: Measuring, calculating, and reducing 
non-target doses present unique challenges with which many 
medical physicists may have limited experience with. The 
American Association of Physicists in Medicine Task Group 
(TG) 158, measurement and calculation of doses outside the 
treatment volume from external-beam radiation therapy 
(EBRT), was created to provide guidance for physicists in 
assessing and managing non-target doses. The primary 
objective of this presentation is to discuss uses of 
dosimeters and phantoms for measuring non-target doses 
from photon, electron, and light-ion EBRT.  
Materials and Methods: The TG-158 reviewed approximately 
300 publications in the literature, twenty percent of which 
focused on measurement techniques, detectors, and 
phantoms for assessment of non-target doses. This 
presentation will highlight key components of Chapter 4 of 
TG-158 report, measurement approaches.  
Results: For measurements of non-target dose in photon and 
electron therapy, the following detectors will be discussed: 
thermo luminescent and optically luminescent dosimeters, 
diodes, metal oxide-silicon semiconductor field effect 
transistor dosimeters, and ion chambers. The use of each 
dosimeter will be presented in the context of (1) dose at the 
surface, (2) energy spectrum, (3) dosimeter dynamic range, 
and (4) presence of other particles.  
This presentation will also summarize various detectors that 
can be used to measure secondary neutrons. Neutron 
detectors are highly energy dependent and thus, knowledge 
of the energy spectrum being measured is essential. The 
secondary neutrons from electron, photon, and light-ion 
therapy have a wide energy range, i.e., from thermal up to 
about 10 MV for photon/electron therapy and thermal up to 
250 MeV for light ion therapy. Moreover, many neutron 
detectors cannot be used in or near the primary field because 
of issues such as pulse-pile-up and interactions of particles 
within the detector, among others. Thus, each neutron 
detector will be presented in the context of its energy 
sensitivity and its suitability for measurements in-or near the 
primary field. 
Finally, the presentation will highlight various issues related 
to phantom selection, including assumptions about organ 
position within anthropomorphic phantoms, adult verses 
pediatric phantoms, and effect of phantoms on neutron 
energy spectra. 
Conclusions: This presentation will highlight the unique 
challenges of measuring non-target doses and will provide 
guidance on how to select the most appropriate detector and 
phantoms for these measurements for photon, electron, and 
light-ion therapy. 
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Purpose/Objective: Validation of the Radiation Therapy 
Oncology Group (RTOG)-endorsed guidelines (Table 1) for 
brachial plexus (BP) contouring by determining the intra- and 
interobserver agreement. Anatomically validated computed 
tomography (CT) and magnetic resonance imaging (MRI) 
datasets were used as a gold standard to determine the 
accuracy of the delineation process. Validation of the BP was 
performed by dissection of all cadavers. 
Materials and Methods: The right BP was delineated on 3 CT 
cadaver datasets by 5 observers. Inter- and intraobserver 
variation was computed using the Computerized Environment 
for Radiation Research (CERR) package. Each observer 
3rd ESTRO Forum 2015                                                                                                                                         S273 
 
delineated the BP 3 times, every time with an interval of 2 
weeks. A detailed statistical analysis was performed on 4 
subregions of the BP. The first region extends from the exit 
of the BP through the intervertebral foramina until the 
entrance of the scalene opening. The second region ends at 
the entrance between the subclavius and serratus anterior 
muscles. The third region was defined between the 
subclavius and serratus anterior muscles. The fourth region 
defines the BP bordered between the minor pectoral, 
subscapular and serratus anterior muscles. The delineation 
accuracy was determined by measuring the BP inclusion of 
the delineations on rigidly fused CT-MRI datasets. 
Results: A low inter- and intraobserver reliability was 
observed. The mean inter- and intraobserver kappa was 
respectively 0.29 and 0.45. The minimum and maximum 
Jaccard index in the intraobserver group was 0.004 and 0.636 
while in the interobserver group 0 and 0.124 was obtained. 
The total agreement volume in both intra- and interobserver 
groups was much lower than the union volume. The overall 
accuracy was poor, with an average inclusion of 38% (Figure 
1) . The accuracy of the delineations reduced from the 
medial to the lateral BP regions. 
Conclusions: Poor inter- and intraobserver reliability of the 
RTOG-endorsed BP contouring guidelines was observed. 
Accuracy analysis showed an average BP inclusion of 38%. BP 
inclusion reduced from the medial to the lateral BP regions. 
Insufficient accuracy and reliability of the RTOG-endorsed BP 
guidelines was observed. 
 
 
Table 1 RTOG-endorsed brachial plexus contouring guidelines 
 
Figure 1 Delineation of the brachial plexus (BP) by one 
observer on a cadaver dataset. In this example the 
delineation shows a 38.43% BP (yellow) inclusion. The defined 
subregions: region 1: green, region 2: red, region 3: blue, 
region 4: orange.  
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Purpose/Objective: Radiotherapy is a critical treatment for 
both medulloblastoma and ependymoma. The literature does 
not assess whether or not to include the roots of posterior 
fossa cranial nerves (CN’s - VII-XII) in the target volume. 
There is also little data describing the anatomy of 
cerebrospinal fluid (CSF) as it follows the roots of these CN’s, 
specifically how far it flows into their respective skull base 
formaniae. The role of MRI, in particular steady-state free 
precession sequences such as FIESTA, in imaging the cisternal 
segments of CN’s, is well described. This study aims to 
determine whether a database of FIESTA images can be used 
to answer this anatomical question and whether this data can 
be used to guide radiotherapy planning.  
Materials and Methods: A database of 97 FIESTA sequences 
of the posterior fossa was reviewed. Examinations were 
excluded for these reasons; sagittal reconstructions only, 
abnormal head shape/anatomy, no FIESTA sequences, limited 
number of slices pulled from archive, structure not clearly 
visualized. Measurements were made on the following 
number of scans for each foramen respectively; 86 left 
internal acoustic meatus (IAM), 84 right IAM, 83 left jugular 
foramen (JF), 85 right JF, 42 left hypoglossal canal (HC), 45 
right HC. A protocol was written to describe how 
measurements should be taken. One author, a senior trainee 
in radiation oncology (observer 1), measured all available 
images. Another, a consultant neuro-radiologist (observer 2), 
measured distances for the first 5 patients on the database 
giving 30 data points for comparative analysis. 
Results: Measurements of the HC were difficult and 
unreliable therefore only measurements of IAM and JF were 
used for comparison between 2 observers. The mean 
distances for observers 1 and 2 respectively were 12.4mm 
and 12.0mm (IAM) and 8.0mm and 7.8mm (JF). Differences 
between measurements were normally distributed; a Band-
Altmann analysis was used to assess agreement. A bias of 
+0.3mm was found for observer 1 relative to observer 2. The 
95% confidence interval for disagreement was -0.4mm to 
1.05mm; this was felt to be clinically acceptable. The mean 
distances of CSF flow in the sample were 12.2mm (95% CI 8.8 
– 15.6mm) for IAM and 7.3mm (95% CI 4.0 – 10.6mm) for JF. 
The distribution of data for the HC was bimodal with peaks 
around 2-4mm and 8-10mm, precluding useful analysis. This 
was because many scans stopped around or just beyond the 
HC’s, resulting in poor image quality. We surmise that longer 
measurements come from scans where the HC was fully 
included. 
Conclusions: FIESTA MRI gives excellent views of the 
posterior fossa CN foraminae and the CSF within. 
Measurement of these spaces is robust and reproducible. We 
intend to use these data to analyse previous treatment plans 
for both medulloblastoma and ependymoma and investigate 
whether specific voluming of these structures has any impact 
on target coverage and whether the CSF in these spaces may 
have been under-treated.  
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Purpose/Objective: READY (REsearch program in Auto 
Delineation sYstem)-LUNG01 is an hypothesis-generating 
prospective study, which has the aim to validate in clinical 
